immunoadsorption plasmapheresis

IAPP

WordNet

1. plasma is separated from whole blood and the rest is returned to the donor

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 難治性の尋常性天疱瘡および落葉状天疱瘡のマネージメント management of refractory pemphigus vulgaris and pemphigus foliaceus
• 2. 抗GBM抗体（グッドパスチャー）病の治療 treatment of anti gbm antibody goodpastures disease
• 3. 腎移植におけるHLAとABOの感作および脱感作 hla and abo sensitization and desensitization in renal transplantation
• 4. 血友病患者における第VIIIおよび第IX因子阻害物質 factor viii and factor ix inhibitors in patients with hemophilia
• 5. 後天性TTP：初期治療 acquired ttp initial treatment

English Journal

• Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses.

• Faissner S1, Nikolayczik J2, Chan A2, Hellwig K2, Gold R2, Yoon MS2, Haghikia A3.
• Journal of neurology.J Neurol.2016 Apr 2. [Epub ahead of print]
• Patients suffering from multiple sclerosis (MS) are treated with high-dose intravenous steroids during acute relapses. In case of steroid refractory relapses, patients are treated with plasmapheresis or immunoadsorption. Until now data concerning the efficacy of both procedures are scarce. Visual ev
• PMID 27039388

• Feasibility of using DNA-immobilized nanocellulose-based immunoadsorbent for systemic lupus erythematosus plasmapheresis.

• Xu C1, Carlsson DO2, Mihranyan A3.
• Colloids and surfaces. B, Biointerfaces.Colloids Surf B Biointerfaces.2016 Mar 7;143:1-6. doi: 10.1016/j.colsurfb.2016.03.014. [Epub ahead of print]
• The goal of this project was to study the feasibility of using a DNA-immobilized nanocellulose-based immunoadsorbent for possible application in medical apheresis such as systemic lupus erythematosus (SLE) treatment. Calf thymus DNA was bound to high surface area nanocellulose membrane at varying co
• PMID 27011345

• Lipoprotein apheresis to treat elevated lipoprotein(a).

• Waldmann E1, Parhofer KG2.
• Journal of lipid research.J Lipid Res.2016 Feb 17. pii: jlr.R056549. [Epub ahead of print]
• An elevated plasma concentration of lipoprotein(a) (Lp(a)) is an independent risk factor for cardiovascular disease. Life style modification and currently available drugs either fail to effectively lower plasma Lp(a) levels or do not result in clinical benefit. However lipoprotein apheresis is very
• PMID 26889050

Japanese Journal

• 関節リウマチ・悪性関節リウマチに対するアフェレシス療法(<特集>血管炎症候群とアフェレシス)

• 日本アフェレシス学会雑誌 34(2), 131-136, 2015-05-31
• NAID 110009964088

• 免疫吸着療法の併用により寛解導入し得た高齢発症ループス腎炎の1例

• 日本透析医学会雑誌 48(7), 443-448, 2015
• NAID 130005090709

• 血漿交換療法 (特集 多発性硬化症と視神経脊髄炎 : 基礎・臨床研究の最新知見) -- (急性増悪期の治療)

• 日本臨床 72(11), 1999-2002, 2014-11
• NAID 40020241584

Related Links

• Clinical Application of Immunoadsorption - UniNet

Clinical Application of Immunoadsorption Rapidly Progressive Glomerulonephritis Plasmapheresis has been shown to be effective in Goodpasture's syndrome [5]. Preliminary results of a controlled trial in Sweden testing ...

• Immunoadsorption plasmapheresis for severe generalised ...

Abstract Two patients with severe generalised myasthenia gravis of childhood were successfully treated with immunoadsorption plasmapheresis. One patient was a 5 year old girl and the other was a 12 year old girl. A ...

---

★リンクテーブル★

リンク元	「血漿浄化療法」「IAPP」
関連記事	「immunoadsorption」

「血漿浄化療法」

　　[★]

英

plasmapheresis, PP

分類

• 血漿交換療法 plasma exchangePE
• 血漿吸着療法 immunoadsorption plasmapheresis IAPP

「IAPP」

　　[★]

• 免疫吸着 immunoadsorption plasmapheresis
• 膵島アミロイドポリペプチド islet amyloid polypeptide

「immunoadsorption」

　　[★]

• 免疫吸着

関

immunosorbent